Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04900298 · ClinicalTrials.gov registry record · NA

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

A NA study of Surgical Wound Infection and Cross Infection, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04900298 is a NA study of Surgical Wound Infection and Cross Infection that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 40 participants, below the 924-participant average among 8 other Surgical Wound Infection trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04900298, a NA study of Surgical Wound Infection and Cross Infection, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that the use of a personal hand hygiene system (SafeHavenTM) by anesthesia providers in the adult operating room, combined with a novel infectious pathogen tracking system (OR PathTrac) will decrease participant exposure to pathologic bacteria in the adult operating room.

Interventions

  • DEVICE SafeHaven Automated Hand Hygiene Device

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-01-01
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT04900298

The ClinicalTrials.gov registry entry for NCT04900298 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 924-participant average among 8 other Surgical Wound Infection trials with a reported enrollment target (96% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Surgical Wound Infection appearing as the primary indexed condition, and to 1 intervention - of which SafeHaven Automated Hand Hygiene Device is the first listed.

NCT04900298 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04900298 about?

NCT04900298 is a clinical study titled "Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System". The investigators hypothesize that the use of a personal hand hygiene system (SafeHavenTM) by anesthesia providers in the adult operating room, combined with a novel infectious pathogen tracking system (OR PathTrac) will decrease participant exposure to pathologic bacteria in the adult operating roo...

What is the current status of trial NCT04900298?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-01-01. Estimated completion is 2026-06-30.

What conditions does trial NCT04900298 study?

This clinical trial studies the following conditions: Surgical Wound Infection, Cross Infection.

What interventions are being tested in trial NCT04900298?

The interventions under investigation include: SafeHaven Automated Hand Hygiene Device (DEVICE).

Who is sponsoring clinical trial NCT04900298?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04900298 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.